CREDO THERAPIES LTD

14441022
Active Oxford

Other human health activities

12 employees website.com
Healthcare and wellbeing Other human health activities
C

CREDO THERAPIES LTD

14441022

Other human health activities

Founded 25 Oct 2022 Active Oxford, United Kingdom 12 employees website.com
Healthcare and wellbeing Other human health activities
Accounts Submitted 24 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 15 Jan 2026 Next due 7 Nov 2026 4 months remaining
Net assets £1M £1M 2024 year on year
Total assets £1M £1M 2024 year on year
Total Liabilities £146K £108K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

8 King Edward Street Oxford OX1 4HL United Kingdom

Website

www.example.com

Full company profile for CREDO THERAPIES LTD (14441022), an active healthcare and wellbeing company based in Oxford, United Kingdom. Incorporated 25 Oct 2022. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

£817.81k

Decreased by £1.47M (-64%)

Net Assets

£1.08M

Decreased by £1.45M (-57%)

Total Liabilities

£145.77k

Increased by £107.53k (+281%)

Turnover

N/A

Employees

12

Increased by 2 (+20%)

Debt Ratio

12%

Increased by 11 (+1100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

6 Allotments 307,985 Shares £33924.10m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
12 May 2025106,011£10.601£0
30 May 202342,404£33923.20m£800k
5 Dec 20224,935£75k£15.198
5 Dec 202244,415£675k£15.198
1 Dec 20229,870£150k£15.198

Officers

Officers

1 active 2 resigned
Status
Gordon, Bruce MalcolmDirectorBritishEngland661 Sept 2025Active

Shareholders

Shareholders (15)

Oxford Science Enterprises Plc
33.7%
106,011
Oxford Science Enterprises Plc
22.9%
72,014

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased
Active
Notified 5 Dec 2022
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 25 To 50 Percent

Cristian Oancea

Ceased 1 Dec 2022

Ceased

David James Bateman

Ceased 1 Dec 2022

Ceased

Group Structure

Group Structure

CREDO THERAPIES LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
24 Feb 2026OfficersTermination of Bruce Malcolm Gordon as director on 22 Jan 2026
24 Feb 2026OfficersTermination of Nicholas Joseph Mercadante as director on 23 Feb 2026
24 Feb 2026OfficersTermination of Joel Schoppig as director on 23 Feb 2026
24 Feb 2026OfficersTermination of Lingyun Shao as director on 24 Feb 2026
21 Jan 2026GazetteGazette Filings Brought Up To Date
24 Feb 2026 Officers

Termination of Bruce Malcolm Gordon as director on 22 Jan 2026

24 Feb 2026 Officers

Termination of Nicholas Joseph Mercadante as director on 23 Feb 2026

24 Feb 2026 Officers

Termination of Joel Schoppig as director on 23 Feb 2026

24 Feb 2026 Officers

Termination of Lingyun Shao as director on 24 Feb 2026

21 Jan 2026 Gazette

Gazette Filings Brought Up To Date

Recent Activity

Latest Activity

Termination of Bruce Malcolm Gordon as director on 22 Jan 2026

3 months ago on 24 Feb 2026

Termination of Nicholas Joseph Mercadante as director on 23 Feb 2026

3 months ago on 24 Feb 2026

Termination of Joel Schoppig as director on 23 Feb 2026

3 months ago on 24 Feb 2026

Termination of Lingyun Shao as director on 24 Feb 2026

3 months ago on 24 Feb 2026

Gazette Filings Brought Up To Date

4 months ago on 21 Jan 2026